Drug discovery

Protein crystallization and X-ray crystallography

In medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are discovered and designed. In the recent past, most drugs have been discovered either by identifying the active ingredient from traditional remedies or by serendipitous discovery. A new approach, using so-called "rational drug design", has been to understand how disease and infection are controlled at the molecular and physiological level and to target specific entities based on this knowledge. Given this importance, Rigaku has been at the forefront in the development of single crystal diffraction for both macromolecular and small molecule structure determination. Our products range from automated crystallization and crystal imaging through crystal diffraction screening and high-resolution data collection systems to 3D structure refinement and imaging software.

X-ray Diffraction systems
  XtaLAB Synergy-R
Single crystal diffraction system with MicroMax-007 HF microfocus rotating anode generator
    XtaLAB Synergy-S
Fast, flexible system with the latest generation sources and HPC detectors, perfect for any crystallography lab.
  XtaLAB Synergy Custom
Single crystal diffraction system with custom enclosure and flexibility for easy integration of accessory components